Zovirax Ointment
NDC Package 0187-0993-95
Package Information
Zovirax (acyclovir) ointment is a medication used to treat "cold sores/fever blisters" (herpes labialis). This formulation utilizes a ointment delivery system. Marketed by Bausch Health Us, Llc, this product is identified by NDC 0187-0993 and is authorized under FDA application NDA018604.
Identification & Billing
- RxCUI: 197312 - acyclovir 5 % Topical Ointment
- RxCUI: 197312 - acyclovir 0.05 MG/MG Topical Ointment
- RxCUI: 197312 - acyclovir 50 MG per 1 GM Topical Ointment
- RxCUI: 197312 - acycycloguanosine 0.05 MG/MG Topical Ointment
- RxCUI: 209977 - Zovirax 5 % Topical Ointment
Clinical Specifications
- DNA Polymerase Inhibitors - [MoA] (Mechanism of Action)
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor - [EPC] (Established Pharmacologic Class)
- Nucleoside Analog - [EXT]
Regulatory & Marketing
Hierarchy Structure
- 0187 - Bausch Health Us, Llc
- 0187-0993 - Zovirax
- 0187-0993-95 - 1 TUBE in 1 CARTON / 30 g in 1 TUBE
- 0187-0993 - Zovirax
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0187-0993-95 identifies a specific commercial package of 1 tube in 1 carton / 30 g in 1 tube of Zovirax, a human prescription drug labeled by Bausch Health Us, Llc. This ointment is formulated for topical use and contains acyclovir as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Us, Llc on March 29, 1982. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat "cold sores/fever blisters" (herpes labialis). It can speed up healing of the sores and decrease symptoms (such as tingling, pain, burning, itching). Acyclovir belongs to a class of medications known as antivirals. It works by stopping the growth of the virus. This medication does not cure herpes, and it does not prevent passing the infection to someone else. It does not prevent a future occurrence.
How is this Bausch Health Us, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00187099395. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.